Evidence map›Paper›PMID 30382864›Full record

ArticleBMC complementary and alternative medicine2018

Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.

Guohua Yu, Wubin Wang, Xu Wang, Meng Xu, Lili Zhang, Lei Ding, Rui Guo, Yuanyuan Shi

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Identification of gene biomarkers with expression profiles in patients with allergic rhinitis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Guohua YuSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Wubin WangSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Xu WangSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Meng XuSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Lili ZhangSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Lei DingSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Rui GuoSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China.
Yuanyuan ShiSchool of Life Sciences, Beijing University of Chinese Medicine, No.11 East road, North 3rd Ring Road, Beijing, 100029, China. yshi@bucm.edu.cn.
Beijing University of Chinese Medicine · CN

Funding

Beijing University of Chinese Medicine No.1000061020013
6 · The paper itself

Abstract

backgroundZuojinwan (ZJW), a classic herbal formula, has been extensively used to treat gastric symptoms in clinical practice in China for centuries. However, the pharmacological mechanisms of ZJW still remain vague to date.

methodsIn the present work, a network pharmacology-based strategy was proposed to elucidate its underlying multi-component, multi-target, and multi-pathway mode of action against gastritis. First we collected putative targets of ZJW based on TCMSP and STITCH databases, and a network containing the interactions between the putative targets of ZJW and known therapeutic targets of gastritis was built. Then four topological parameters, "degree", "betweenness", "closeness", and "coreness" were calculated to identify the major targets in the network. Furthermore, the major hubs were imported to the Metacore database to perform a pathway enrichment analysis.

resultsA total of 118 nodes including 59 putative targets of ZJW were picked out as major hubs in terms of their topological importance. The results of pathway enrichment analysis indicated that putative targets of ZJW mostly participated in various pathways associated with anti-inflammation response, growth and development promotion and G-protein-coupled receptor signaling. More importantly, five putative targets of ZJW (EGFR, IL-6, IL-1β, TNF-α and MCP-1) and two known therapeutic targets of gastritis (CCKBR and IL-12β) and a link target NF-κB were recognized as active factors involved in the main biological functions of treatment, implying the underlying mechanisms of ZJW acting on gastritis.

conclusionZJW could alleviate gastritis through the molecular mechanisms predicted by network pharmacology, and this research demonstrates that the network pharmacology approach can be an effective tool to reveal the mechanisms of traditional Chinese medicine (TCM) from a holistic perspective.

Indexed as

Chemokine CCL2Drugs, Chinese HerbalGastritisGene Regulatory NetworksHumansInterleukin-6NF-kappa BSignal TransductionCCL2 protein, humanChemokine CCL2Drugs, Chinese HerbalInterleukin-6NF-kappa BGastritisNetwork pharmacologyZuojinwan

Identifiers

PMID30382864
PMCPMC6211468
OpenAlexW2899133544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.